Skip to main content

Meeting Highlights

Meeting Highlights

AACR Highlights

Two Ways to Target Tumors with KRAS Mutations

Meeting Highlights

GI Cancers Symposium Highlights, Pancreatic Cancer

Gemcitabine-Cisplatin Combination a New Standard in Pancreatic Cancer with Germline BRCA or PALB2 Mutation

Meeting Highlights

GI Cancers Symposium Highlights, Colorectal Cancer

Encorafenib plus Cetuximab Improves Quality of Life versus Standard of Care in Colorectal Cancer Associated with BRAF Mutation

Meeting Highlights

GI Cancers Symposium Highlights, Hepatocellular Carcinoma

Atezolizumab-Bevacizumab Combo Improves Survival and Quality of Life in Unresectable Liver Cancer

Meeting Highlights

GU Cancers Symposium Highlights, Renal-Cell Carcinoma

Sitravatinib, Novel TKI, plus Nivolumab Elicits Good Responses in Renal-Cell Carcinoma

Meeting Highlights

GU Cancers Symposium Highlights, Renal-Cell Carcinoma

First-in-Class Oral MK-6482 Shows Exciting Results in Clear-Cell Renal-Cell Carcinoma

Meeting Highlights

ESMO Highlights

Targeted Therapy with Olaparib Beneficial in Metastatic Prostate Cancer with Gene Mutations

Meeting Highlights

ASH Highlights, CAR T-Cell Therapy, Lymphoma

Mosunetuzumab, a Dual-Targeted Antibody, Shows Complete Remissions in Relapsed/Refractory NHL After CAR T-Cell Therapy

Meeting Highlights

ASH Highlights, CAR T-Cell Therapy, Immunotherapy

Apamistamab-Based Lymphodepleting Regimen Before CAR T-Cell Therapy Prevents Cytokine Release Syndrome

Meeting Highlights

ASH Highlights, Leukemia

Zanubrutinib, Next-Generation BTK, Leads to Impressive Responses in Patients with CLL or SLL

2
3
4
5
6
7
8

Page 5 of 8
Results 41 - 50 of 72